of Screening Compounds
Drug Discovery Services
Pharma News, 2019
UTA scientist explores using nanoparticles to reduce size of deep-seated tumors
Another collaborative project from a nanoparticles expert at The University of Texas at Arlington has yielded promising results in the search for more effective, targeted cancer treatments.
Tuberculosis mutation discovery paves way for better treatments
PNAS publishes Rutgers New Jersey Medical school study.
Tricida Announces Submission of New Drug Application for Veverimer for the Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease
SOUTH SAN FRANCISCO, Calif.
Israeli researchers develop antibacterial coating for implants to prevent infections
FDA Singles Out 9 More Drug Substances Not for Compounding
FDA Singles Out 9 More Drug Substances Not for CompoundingFollowing a court win late last month to keep one such drug substance out of the hands of compounders, the US Food and Drug Administration ...
Allergan : Receives FDA Approval of Juvederm VOLUMA XC for Mid-Face Injection via Cannula
DUBLIN - Allergan plc (NYSE.
'Daily' cocaine use changes genes in the brain and fuels addiction, study finds
Chronic cocaine use could alter genes in your brain and contribute to addiction, a new study finds.
A blood test could predict heart disease and early death risks 40 YEARS in advance, study suggests
A blood test for signs of inflammation in young people may predict their risks of heart disease and an early death, a new study suggests.
FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease
Endo and Allergan settle opioid case ahead of trial
The two pharma companies have agreed to pay $15 million to certain Ohio counties before an opioid abuse trial to be held in October.
Mylan generic of lung cancer drug Alimta approved
Mylan NV’s generic version Eli Lilly and Co’s lung cancer drug, Alimta, has been given tentative approval by the FDA.
A new drug could revolutionize the treatment of neurological disorders
The international team of scientists from Gero Discovery LLC, the Institute of Biomedical Research of Salamanca, and Nanosyn, Inc.
Go to cart
You will be able to Pay Online or Request a Quote
Catalog of Screening Compounds
Focused and Target Libraries
Active Reference Sets
Drug Discovery Services
In silico Drug Design (CADD)
Toxicology and Safety
Chemistry, Manufacturing and Controls
News & Media
Trends in discovery compounds